Kim M, Kim J, Rhim W, Cimaglia G, Want A, Morgan J
Acta Neuropathol Commun. 2024; 12(1):65.
PMID: 38649962
PMC: 11036688.
DOI: 10.1186/s40478-024-01777-0.
Al-Hawary S, Habash R, Abosaooda M, Hjazi A, Musad Saleh E, Hassan Z
Heliyon. 2024; 10(4):e25605.
PMID: 38370200
PMC: 10867653.
DOI: 10.1016/j.heliyon.2024.e25605.
Raju R, Abuwatfa W, Pitt W, Husseini G
Pharmaceuticals (Basel). 2023; 16(8).
PMID: 37630971
PMC: 10458450.
DOI: 10.3390/ph16081056.
Wang T, Wu C, Hu Y, Zhang Y, Ma J
RSC Adv. 2023; 13(24):16488-16511.
PMID: 37274408
PMC: 10233443.
DOI: 10.1039/d3ra00866e.
Gyanani V, Goswami R
Pharmaceutics. 2023; 15(4).
PMID: 37111668
PMC: 10144967.
DOI: 10.3390/pharmaceutics15041184.
Liposomes in Cancer Therapy: How Did We Start and Where Are We Now.
Fulton M, Najahi-Missaoui W
Int J Mol Sci. 2023; 24(7).
PMID: 37047585
PMC: 10095497.
DOI: 10.3390/ijms24076615.
DOPE/CHEMS-Based EGFR-Targeted Immunoliposomes for Docetaxel Delivery: Formulation Development, Physicochemical Characterization and Biological Evaluation on Prostate Cancer Cells.
da Silva Moreira T, Silva A, Vasconcelos B, da Silva Santos E, Carolina Cruz de Sousa A, Barroso de Freitas J
Pharmaceutics. 2023; 15(3).
PMID: 36986777
PMC: 10052572.
DOI: 10.3390/pharmaceutics15030915.
What We Need to Know about Liposomes as Drug Nanocarriers: An Updated Review.
Abbasi H, Kouchak M, Mirveis Z, Hajipour F, Khodarahmi M, Rahbar N
Adv Pharm Bull. 2023; 13(1):7-23.
PMID: 36721822
PMC: 9871273.
DOI: 10.34172/apb.2023.009.
Phosphorothioated amino-AS1411 aptamer functionalized stealth nanoliposome accelerates bio-therapeutic threshold of apigenin in neoplastic rat liver: a mechanistic approach.
Dhara M, Hoque A, Sen R, Dutta D, Mukherjee B, Paul B
J Nanobiotechnology. 2023; 21(1):28.
PMID: 36694259
PMC: 9875447.
DOI: 10.1186/s12951-022-01764-4.
Enhancing the therapeutic efficacy of nanoparticles for cancer treatment using versatile targeted strategies.
Tian H, Zhang T, Qin S, Huang Z, Zhou L, Shi J
J Hematol Oncol. 2022; 15(1):132.
PMID: 36096856
PMC: 9469622.
DOI: 10.1186/s13045-022-01320-5.
Appraisal for the Potential of Viral and Nonviral Vectors in Gene Therapy: A Review.
Butt M, Zaman M, Ahmad A, Khan R, Mallhi T, Hasan M
Genes (Basel). 2022; 13(8).
PMID: 36011281
PMC: 9407213.
DOI: 10.3390/genes13081370.
Non-Viral Vectors for Delivery of Nucleic Acid Therapies for Cancer.
Kanvinde S, Kulkarni T, Deodhar S, Bhattacharya D, Dasgupta A
BioTech (Basel). 2022; 11(1).
PMID: 35822814
PMC: 9245904.
DOI: 10.3390/biotech11010006.
Fluorinated PEG-PEI Coated Magnetic Nanoparticles for siRNA Delivery and CXCR4 Knockdown.
Cao Y, Zhang S, Ma M, Zhang Y
Nanomaterials (Basel). 2022; 12(10).
PMID: 35630915
PMC: 9146302.
DOI: 10.3390/nano12101692.
Polymer-Modified Liposomes for Drug Delivery: From Fundamentals to Applications.
Cao Y, Dong X, Chen X
Pharmaceutics. 2022; 14(4).
PMID: 35456613
PMC: 9026371.
DOI: 10.3390/pharmaceutics14040778.
Calcium Enabled Remote Loading of a Weak Acid Into pH-sensitive Liposomes and Augmented Cytosolic Delivery to Cancer Cells via the Proton Sponge Effect.
Yang M, Yarragudi S, Jamieson S, Tang M, Wilson W, Wu Z
Pharm Res. 2022; 39(6):1181-1195.
PMID: 35229237
PMC: 9197910.
DOI: 10.1007/s11095-022-03206-0.
The involvement of extracellular vesicles in the transcytosis of nanoliposomes through brain endothelial cells, and the impact of liposomal pH-sensitivity.
Reginald-Opara J, Svirskis D, Paek S, Tang M, OCarroll S, Dean J
Mater Today Bio. 2022; 13:100212.
PMID: 35198960
PMC: 8841812.
DOI: 10.1016/j.mtbio.2022.100212.
Mechanistic Insight into How PEGylation Reduces the Efficacy of pH-Sensitive Liposomes from Molecular Dynamics Simulations.
Mahmoudzadeh M, Magarkar A, Koivuniemi A, Rog T, Bunker A
Mol Pharm. 2021; 18(7):2612-2621.
PMID: 34096310
PMC: 8289284.
DOI: 10.1021/acs.molpharmaceut.1c00122.
Recent Advances in pH- or/and Photo-Responsive Nanovehicles.
Shin Y, Husni P, Kang K, Lee D, Lee S, Lee E
Pharmaceutics. 2021; 13(5).
PMID: 34069233
PMC: 8157172.
DOI: 10.3390/pharmaceutics13050725.
Innovations in Biomaterial Design toward Successful RNA Interference Therapy for Cancer Treatment.
Ward D, Shodeinde A, Peppas N
Adv Healthc Mater. 2021; 10(13):e2100350.
PMID: 33973393
PMC: 8273125.
DOI: 10.1002/adhm.202100350.
Recent Advances in Lipid-Based Nanosystems for Gemcitabine and Gemcitabine-Combination Therapy.
Habib S, Singh M
Nanomaterials (Basel). 2021; 11(3).
PMID: 33673636
PMC: 7997169.
DOI: 10.3390/nano11030597.